Thomas Buijsman | Associate Director, Medical Affairs, Oncology
Gilead

Thomas Buijsman is an accomplished professional with extensive experience in the pharmaceutical industry, currently serving as the Associate Director of Medical Affairs in Oncology at Gilead Sciences. With a strong background in healthcare and a focus on oncology, Thomas is dedicated to improving patient outcomes and advancing the field of medicine.

Throughout his career, Thomas has demonstrated a deep understanding of healthcare, access, and evidence-based practices. He has a proven track record of developing and implementing strategies that enhance patient access to life-saving treatments while ensuring the sustainability of healthcare systems.

Thomas is a strategic thinker with a passion for innovation and collaboration. He excels at building strong relationships with key stakeholders, including healthcare providers, payers, and patient advocacy groups. His ability to navigate complex healthcare landscapes and drive meaningful change makes him a valuable asset to any organization.

At the World EPA Congress 2026, Europe’s Leading Healthcare Pricing, Access, and Evidence Congress, Thomas will share his insights and expertise on the latest insights regarding accessibility to cancer drugs, making comparisons between EU countries and a selection of solid tumors. These insights are showing inequity to cancer care.

Overall, Thomas Buijsman is a dynamic leader in the field of medical affairs, dedicated to making a difference in the lives of patients and shaping the future of healthcare. His commitment to excellence and passion for innovation make him a sought-after speaker and thought leader in the industry.